burn scar. Atrophic disorders of skin
Conditions
Interventions
Intervention 1: Patients with the deka fractional CO2 laser, along with 2 cc of SVF cells, will receive three sessions one month apart. Intervention 2: Control group: Patients will receive fractional
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with skin type 1-4 Patients with atrophic burn scars in more than one organ from 5 years ago to 3 months ago
Exclusion criteria
Exclusion criteria: Age under 18 years Patients who have received laser treatment in the last three months Patients with active colloidal scar or active skin lesion at the injection site Patients with coagulation and platelet disorders Patients with a history of underlying disease such as diabetes and autoimmune connective tissue disease that affect wound healing Patients with active viral infections Patients with a history of anticoagulants History of malignancy or receiving chemotherapy Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scar size. Timepoint: before and 2 month after the intervention. Method of measurement: visioface. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One week after treatment. Method of measurement: Questionnaire and visit.;Patient Satisfaction. Timepoint: Two months after treatment. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem Cell Research Center, Tehran University of Medical Sciences
Outcome results
None listed